 | • レポートコード：MRC23Q35782 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の抗生物質市場について調査・分析し、世界の抗生物質市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（ペニシリン、アミノグリコシド、テトラサイクリン、クロラムフェニコール、マクロライド、その他）、用途別セグメント分析（病院、診療所）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Pfizer、Abbvie、Novartis AG、Merck & Co. Inc、GlaxoSmithKline、Apotex、Hanmi Cepha Plant、Globela Pharma、Bausch Health、Teva Pharmaceutical Industries Limited、Bristol-Myers Squibb Company、Mylan、Sanofi、ACS Dobfar S.p.A、Spero Therapeutics、Savior Lifetecなどが含まれています。世界の抗生物質市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、抗生物質市場規模を推定する際に考慮しました。本レポートは、抗生物質の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、抗生物質に関するビジネス上の意思決定に役立てることを目的としています。 ・抗生物質市場の概要 - 抗生物質のタイプ別セグメント - 世界の抗生物質市場規模：タイプ別分析（ペニシリン、アミノグリコシド、テトラサイクリン、クロラムフェニコール、マクロライド、その他） - 抗生物質の用途別セグメント - 世界の抗生物質市場規模：用途別分析（病院、診療所） - 世界の抗生物質市場規模予測（2018年-2029年） ・抗生物質市場の成長トレンド - 抗生物質の地域別市場規模（2018年-2029年） - 抗生物質市場ダイナミクス - 抗生物質の業界動向 - 抗生物質市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：ペニシリン、アミノグリコシド、テトラサイクリン、クロラムフェニコール、マクロライド、その他 - 世界の抗生物質のタイプ別市場規模（2018年-2023年） - 世界の抗生物質のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、診療所 - 世界の抗生物質の用途別市場規模（2018年-2023年） - 世界の抗生物質の用途別市場規模（2024年-2029年） ・抗生物質の地域別市場規模 - 北米の抗生物質市場規模（2018年-2029年） - アメリカの抗生物質市場規模（2018年-2029年） - ヨーロッパの抗生物質市場規模（2018年-2029年） - アジア太平洋の抗生物質市場規模（2018年-2029年） - 中国の抗生物質市場規模（2018年-2029年） - 日本の抗生物質市場規模（2018年-2029年） - 韓国の抗生物質市場規模（2018年-2029年） - インドの抗生物質市場規模（2018年-2029年） - オーストラリアの抗生物質市場規模（2018年-2029年） - 中南米の抗生物質市場規模（2018年-2029年） - 中東・アフリカの抗生物質市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Pfizer、Abbvie、Novartis AG、Merck & Co. Inc、GlaxoSmithKline、Apotex、Hanmi Cepha Plant、Globela Pharma、Bausch Health、Teva Pharmaceutical Industries Limited、Bristol-Myers Squibb Company、Mylan、Sanofi、ACS Dobfar S.p.A、Spero Therapeutics、Savior Lifetec ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Antibiotic Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Antibiotic Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Antibiotic Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Antibiotic Drug in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Antibiotic Drug include Pfizer, Abbvie, Novartis AG, Merck & Co. Inc, GlaxoSmithKline, Apotex, Hanmi Cepha Plant, Globela Pharma and Bausch Health, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antibiotic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibiotic Drug.
The Antibiotic Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Antibiotic Drug market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibiotic Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Pfizer
Abbvie
Novartis AG
Merck & Co. Inc
GlaxoSmithKline
Apotex
Hanmi Cepha Plant
Globela Pharma
Bausch Health
Teva Pharmaceutical Industries Limited
Bristol-Myers Squibb Company
Mylan
Sanofi
ACS Dobfar S.p.A
Spero Therapeutics
Savior Lifetec
Segment by Type
Penicillins
Aminoglycosides
Tetracyclines
Chloramphenicol
Macrolides
Others
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibiotic Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibiotic Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Penicillins
1.2.3 Aminoglycosides
1.2.4 Tetracyclines
1.2.5 Chloramphenicol
1.2.6 Macrolides
1.2.7 Others
1.3 Market by Application
1.3.1 Global Antibiotic Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibiotic Drug Market Perspective (2018-2029)
2.2 Antibiotic Drug Growth Trends by Region
2.2.1 Global Antibiotic Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Antibiotic Drug Historic Market Size by Region (2018-2023)
2.2.3 Antibiotic Drug Forecasted Market Size by Region (2024-2029)
2.3 Antibiotic Drug Market Dynamics
2.3.1 Antibiotic Drug Industry Trends
2.3.2 Antibiotic Drug Market Drivers
2.3.3 Antibiotic Drug Market Challenges
2.3.4 Antibiotic Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibiotic Drug Players by Revenue
3.1.1 Global Top Antibiotic Drug Players by Revenue (2018-2023)
3.1.2 Global Antibiotic Drug Revenue Market Share by Players (2018-2023)
3.2 Global Antibiotic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antibiotic Drug Revenue
3.4 Global Antibiotic Drug Market Concentration Ratio
3.4.1 Global Antibiotic Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibiotic Drug Revenue in 2022
3.5 Antibiotic Drug Key Players Head office and Area Served
3.6 Key Players Antibiotic Drug Product Solution and Service
3.7 Date of Enter into Antibiotic Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibiotic Drug Breakdown Data by Type
4.1 Global Antibiotic Drug Historic Market Size by Type (2018-2023)
4.2 Global Antibiotic Drug Forecasted Market Size by Type (2024-2029)
5 Antibiotic Drug Breakdown Data by Application
5.1 Global Antibiotic Drug Historic Market Size by Application (2018-2023)
5.2 Global Antibiotic Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Antibiotic Drug Market Size (2018-2029)
6.2 North America Antibiotic Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Antibiotic Drug Market Size by Country (2018-2023)
6.4 North America Antibiotic Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antibiotic Drug Market Size (2018-2029)
7.2 Europe Antibiotic Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Antibiotic Drug Market Size by Country (2018-2023)
7.4 Europe Antibiotic Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibiotic Drug Market Size (2018-2029)
8.2 Asia-Pacific Antibiotic Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Antibiotic Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Antibiotic Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antibiotic Drug Market Size (2018-2029)
9.2 Latin America Antibiotic Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Antibiotic Drug Market Size by Country (2018-2023)
9.4 Latin America Antibiotic Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibiotic Drug Market Size (2018-2029)
10.2 Middle East & Africa Antibiotic Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Antibiotic Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Antibiotic Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Antibiotic Drug Introduction
11.1.4 Pfizer Revenue in Antibiotic Drug Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Abbvie
11.2.1 Abbvie Company Detail
11.2.2 Abbvie Business Overview
11.2.3 Abbvie Antibiotic Drug Introduction
11.2.4 Abbvie Revenue in Antibiotic Drug Business (2018-2023)
11.2.5 Abbvie Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Detail
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Antibiotic Drug Introduction
11.3.4 Novartis AG Revenue in Antibiotic Drug Business (2018-2023)
11.3.5 Novartis AG Recent Development
11.4 Merck & Co. Inc
11.4.1 Merck & Co. Inc Company Detail
11.4.2 Merck & Co. Inc Business Overview
11.4.3 Merck & Co. Inc Antibiotic Drug Introduction
11.4.4 Merck & Co. Inc Revenue in Antibiotic Drug Business (2018-2023)
11.4.5 Merck & Co. Inc Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Antibiotic Drug Introduction
11.5.4 GlaxoSmithKline Revenue in Antibiotic Drug Business (2018-2023)
11.5.5 GlaxoSmithKline Recent Development
11.6 Apotex
11.6.1 Apotex Company Detail
11.6.2 Apotex Business Overview
11.6.3 Apotex Antibiotic Drug Introduction
11.6.4 Apotex Revenue in Antibiotic Drug Business (2018-2023)
11.6.5 Apotex Recent Development
11.7 Hanmi Cepha Plant
11.7.1 Hanmi Cepha Plant Company Detail
11.7.2 Hanmi Cepha Plant Business Overview
11.7.3 Hanmi Cepha Plant Antibiotic Drug Introduction
11.7.4 Hanmi Cepha Plant Revenue in Antibiotic Drug Business (2018-2023)
11.7.5 Hanmi Cepha Plant Recent Development
11.8 Globela Pharma
11.8.1 Globela Pharma Company Detail
11.8.2 Globela Pharma Business Overview
11.8.3 Globela Pharma Antibiotic Drug Introduction
11.8.4 Globela Pharma Revenue in Antibiotic Drug Business (2018-2023)
11.8.5 Globela Pharma Recent Development
11.9 Bausch Health
11.9.1 Bausch Health Company Detail
11.9.2 Bausch Health Business Overview
11.9.3 Bausch Health Antibiotic Drug Introduction
11.9.4 Bausch Health Revenue in Antibiotic Drug Business (2018-2023)
11.9.5 Bausch Health Recent Development
11.10 Teva Pharmaceutical Industries Limited
11.10.1 Teva Pharmaceutical Industries Limited Company Detail
11.10.2 Teva Pharmaceutical Industries Limited Business Overview
11.10.3 Teva Pharmaceutical Industries Limited Antibiotic Drug Introduction
11.10.4 Teva Pharmaceutical Industries Limited Revenue in Antibiotic Drug Business (2018-2023)
11.10.5 Teva Pharmaceutical Industries Limited Recent Development
11.11 Bristol-Myers Squibb Company
11.11.1 Bristol-Myers Squibb Company Company Detail
11.11.2 Bristol-Myers Squibb Company Business Overview
11.11.3 Bristol-Myers Squibb Company Antibiotic Drug Introduction
11.11.4 Bristol-Myers Squibb Company Revenue in Antibiotic Drug Business (2018-2023)
11.11.5 Bristol-Myers Squibb Company Recent Development
11.12 Mylan
11.12.1 Mylan Company Detail
11.12.2 Mylan Business Overview
11.12.3 Mylan Antibiotic Drug Introduction
11.12.4 Mylan Revenue in Antibiotic Drug Business (2018-2023)
11.12.5 Mylan Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Detail
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Antibiotic Drug Introduction
11.13.4 Sanofi Revenue in Antibiotic Drug Business (2018-2023)
11.13.5 Sanofi Recent Development
11.14 ACS Dobfar S.p.A
11.14.1 ACS Dobfar S.p.A Company Detail
11.14.2 ACS Dobfar S.p.A Business Overview
11.14.3 ACS Dobfar S.p.A Antibiotic Drug Introduction
11.14.4 ACS Dobfar S.p.A Revenue in Antibiotic Drug Business (2018-2023)
11.14.5 ACS Dobfar S.p.A Recent Development
11.15 Spero Therapeutics
11.15.1 Spero Therapeutics Company Detail
11.15.2 Spero Therapeutics Business Overview
11.15.3 Spero Therapeutics Antibiotic Drug Introduction
11.15.4 Spero Therapeutics Revenue in Antibiotic Drug Business (2018-2023)
11.15.5 Spero Therapeutics Recent Development
11.16 Savior Lifetec
11.16.1 Savior Lifetec Company Detail
11.16.2 Savior Lifetec Business Overview
11.16.3 Savior Lifetec Antibiotic Drug Introduction
11.16.4 Savior Lifetec Revenue in Antibiotic Drug Business (2018-2023)
11.16.5 Savior Lifetec Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
